Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study

por Holz, Frank G., Minnella, Angelo M., Tuli, Raman, Yoganathan, Pradeepa, Parikh, Soumil, Hamilton, Robin
Publicado 2020

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

por Prünte, Christian, Fajnkuchen, Franck, Mahmood, Sajjad, Ricci, Federico, Hatz, Katja, Studnička, Jan, Bezlyak, Vladimir, Parikh, Soumil, Stubbings, William John, Wenzel, Andreas, Figueira, João
Publicado 2016

REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS Study

por Koh, Adrian, Lai, Timothy Y.Y., Wei, Wen Bin, Mori, Ryusaburo, Wakiyama, Harumi, Park, Kyu Hyung, Ngah, Fariza, Macfadden, Wayne, Dunger-Baldauf, Cornelia, Parikh, Soumil
Publicado 2020

Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study

por Mitchell, Paul, Sheidow, Tom G., Farah, Michel E., Mahmood, Sajjad, Minnella, Angelo M., Eter, Nicole, Eldem, Bora, Al-Dhibi, Hassan, Macfadden, Wayne, Parikh, Soumil, Dunger-Baldauf, Cornelia, Mahgoub, Mohamed M., Schmidt-Erfurth, Ursula
Publicado 2020